Skip to main content
. 2021 Dec 28;45(1):103–119. doi: 10.1007/s13402-021-00654-5

Fig. 4.

Fig. 4

Effect of SPINT2 on CDKN1A (p21) expression is mediated via promotor acetylation. A Chromatin immunoprecipitation of p53 with defined regulatory elements within the CDKN1A promoter. B Nuclear enrichment of p53 after siRNA knockdown of SPINT2. NT: non-targeting siRNA control. Mean and SD of three independent experiments are shown. T test, * p < 0.05; ** p < 0.01. C Representative immunoblot of p53 and p21 in HCT116 and two SPINT2 knockout clones, S15 and S40, after TSA and doxorubicin (DOX) treatment. Ponceau staining was used as a loading control. D, E Quantification of p53 and p21 levels from three independent experiments normalized to the loading control. Mean with SD is shown. T test. * p < 0.05; ** p < 0.01